JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyohara, J.
Right arrow Articles by Fujibayashi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toyohara, J.
Right arrow Articles by Fujibayashi, Y.
Journal of Nuclear Medicine Vol. 43 No. 9 1218-1226
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Rationale of 5-125I-Iodo-4'-Thio-2'-Deoxyuridine as a Potential Iodinated Proliferation Marker

Jun Toyohara, MS1, Akio Hayashi, PhD1, Mikiko Sato, MS1, Hiromichi Tanaka, PhD2, Kazuhiro Haraguchi, PhD2, Yuichi Yoshimura, PhD2, Yoshiharu Yonekura, MD, PhD3 and Yasuhisa Fujibayashi, PhD, DMedSci3

1 Research and Development Division, Research Center, Nihon Medi-Physics Company, Limited, Chiba, Japan
2 School of Pharmaceutical Science, Showa University, Tokyo, Japan
3 Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan

The aim of this investigation was to synthesize and test a novel metabolically stable iodinated nucleoside as a proliferation-imaging agent for SPECT. Methods: 5-Iodo-4'-thio-2'-deoxyuridine (ITdU) and 5-iodo-1-(4-thio-ß-D-arabinofuranosyl)uracil (ITAU) were tested. The radiolabeling of ITdU and ITAU with 125I was achieved by a destannylation reaction of the trimethylstannyl precursor of each nucleoside. The products were isolated in high yields and with >99% radiochemical purities. Results: 125I-ITdU was effectively phosphorylated by cytosolic nucleoside kinases and specifically incorporated into a thymidine kinase-expressing L-M cell rather than a thymidine kinase-deficient mutant L-M (TK-) cell. In addition, an in vitro cell metabolism study of 125I-ITdU clarified that 125I-ITdU was effectively and specifically incorporated into a DNA fraction (>90% at 60 min). Therefore, 125I-ITdU was proven to be an ideal DNA synthesis marker such as 5-125I-iodo-2'-deoxyuridine (IUdR). In contrast, 125I-ITAU was neither remarkably phosphorylated by cytosolic nucleoside kinases nor notably incorporated into an L-M cell rather than an L-M (TK-) cell. 125I-ITdU and 125I-ITAU showed a higher resistance to phosphorolytic cleavage by recombinant thymidine phosphorylase than did 125I-IUdR. Furthermore, biodistribution of 125I-ITdU and 125I-ITAU revealed better in vivo stability of radioiodination than that of 125I-IUdR. 125I-ITdU also displayed a significantly higher uptake in proliferating organs (thymus, spleen, small intestine, and bone) than in nonproliferating organs (brain, muscle, liver, and lung), as did 125I-IUdR, at 18 h after injection. As indicated by the in vitro study, 125I-ITAU did not show any significant uptake in proliferating organs. Conclusion: Radioiodine-labeled ITdU is potentially useful as a proliferation-imaging agent, and further studies should clarify the usefulness of this compound as a tumor-imaging agent.

Key Words: 5-125I-iodo-4'-thio-2'-deoxyuridine • 5-125I-iodo-1-(4-thio-ß-D-arabinofuranosyl)uracil • 5-125I-iodo-2'-deoxyuridine • nucleoside kinases • thymidine phosphorylase




This article has been cited by other articles:


Home page
JNMHome page
S. N. Reske, S. Deisenhofer, G. Glatting, B. D. Zlatopolskiy, A. Morgenroth, A. T. J. Vogg, A. K. Buck, and C. Friesen
123I-ITdU-Mediated Nanoirradiation of DNA Efficiently Induces Cell Kill in HL60 Leukemia Cells and in Doxorubicin-, {beta}-, or {gamma}-Radiation-Resistant Cell Lines
J. Nucl. Med., June 1, 2007; 48(6): 1000 - 1007.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Toyohara, K. Kumata, K. Fukushi, T. Irie, and K. Suzuki
Evaluation of 4'-[Methyl-14C]Thiothymidine for In Vivo DNA Synthesis Imaging
J. Nucl. Med., October 1, 2006; 47(10): 1717 - 1722.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Toyohara, A. Gogami, A. Hayashi, Y. Yonekura, and Y. Fujibayashi
Pharmacokinetics and Metabolism of 5-125I-Iodo-4'-Thio-2'-Deoxyuridine in Rodents
J. Nucl. Med., October 1, 2003; 44(10): 1671 - 1676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.